Search results
Results from the WOW.Com Content Network
Frances Arnold, who won the chemistry Nobel Prize in 2018 and sits on Iambic's board, told Reuters the development represented a major advance in the use of AI for drug discovery.
Google Deepmind has unveiled the third major version of its "AlphaFold" artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the ...
Artificial intelligence in pharmacy is the application of artificial intelligence (AI) [1] [2] [3] to the discovery, development, and the treatment of patients with medications. [4] AI in pharmacy practices has the potential to revolutionize all aspects of pharmaceutical research as well as to improve the clinical application of pharmaceuticals ...
Medical Technology Schools reports that with artificial intelligence, pharmaceutical companies can accelerate the drug discovery process, enhance the precision of targeting specific diseases, and ...
SOM Innovation Biotech, S.A. (SOM Biotech), is a private pharmaceutical company focused on the accelerated discovery and development of therapies for orphan diseases through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies.
AI has been explored for use in cancer diagnosis, risk stratification, molecular characterization of tumors, and cancer drug discovery. A particular challenge in oncologic care that AI is being developed to address is the ability to accurately predict which treatment protocols will be best suited for each patient based on their individual ...
The new funding was raised to "accelerate the development of its large quantitative models (LQMs) and other AI applications in drug discovery, materials science, chemistry, cybersecurity ...
The company "applies DL, big data, and genomis for in silico drug discovery" for various conditions. [2] It has sought to develop AI to "identify novel drug targets for untreated diseases", and has pursued dual-purpose therapeutics, "going after a specific disease or several diseases while targeting ageing at the same time".